(Reuters) -Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a ...

Pfizer shares, which had risen Tuesday morning after improved demand for the Covid vaccine, dropped 2.3% after Kennedy's ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

R obert F. Kennedy Jr., President Trump’s pick to head the U.S. Department of Health and Human Services (HHS), was grilled by ...

Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...

Trump's executive orders for the Pentagon will fulfill campaign promises that the Republican reiterated during last week's ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

George Rodrique sued Hearst Stations and Hearst Communications, WCVB’s owner, in late 2022 over his termination the year ...

(HealthDay News) — Three main themes may largely explain COVID-19 vaccine hesitancy among Black women in the United States: mistrust in health care and government, concerns over vaccine safety, and ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...